Tuberculosis treatment: exploring the perspectives for personalised therapy

TB is a devastating disease that affects people of all ages across the globe. The success of TB treatment depends on several parameters, and there is a great interest for the transition from programmatic to personalised TB management. Thus, there is a critical need for innovative new technologies for treatment response monitoring, and for the development of blood-based biomarkers together with an understanding of population pharmacogenomics.

The involvement of experienced scientists from Riga Stradiņš University (RSU), the Latvian Biomedical Research and Study Centre, and te Institute of Organic Chemistry is planned for this collaborative research project that combines expertise in clinical research, molecular biology and chemistry. The implementation of this project will develop new knowledge and tools, strengthen the laboratories and promote the training of new professionals.